SCOPUS 정보 검색 플랫폼

Volumn 58, Issue 1, 2014, Pages 624-625

First three neisseria gonorrhoeae isolates with high-Level resistance to azithromycin in sweden: A threat to currently available dual-Antimicrobial regimens for treatment of gonorrhea?

(3) Unemo, Magnus a Golparian, Daniel a Hellmark, Bengt a

a ÖREBRO UNIVERSITY HOSPITAL (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; RNA 23S;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATION; GONORRHEA; HUMAN; LETTER; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; SWEDEN;

ANTI-INFECTIVE AGENTS; AZITHROMYCIN; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; SWEDEN;

EID: 84891515944 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.02093-13 Document Type: Letter

Times cited : (54)

References (13)

1
- 70350627375
- Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae
- Tapsall JW, Ndowa F, Lewis DA, Unemo M. 2009. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7:821-834. http://dx.doi.org/10.1586/eri.09.63
- (2009) Expert Rev. Anti Infect. Ther. , vol.7 , pp. 821-834
- Tapsall, J.W.¹ Ndowa, F.² Lewis, D.A.³ Unemo, M.⁴

2
- 84870891391
- Emergence of multidrug-resistant, extensively drug-Resistant and untreatable gonorrhea
- Unemo M, Nicholas RA. 2012. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7:1401-1422. http://dx.doi.org/10.2217/fmb.12.117
- (2012) Future Microbiol , vol.7 , pp. 1401-1422
- Unemo, M.¹ Nicholas, R.A.²

3
- 84884922548
- Phenotypic and genetic characterization of the first two cases of extended-Spectrumcephalosporin- Resistant neisseria gonorrhoeae infection in south africa and association with cefixime treatment failure
- Lewis DA, Sriruttan C, Müller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M. 2013. Phenotypic and genetic characterization of the first two cases of extended-spectrumcephalosporin- resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J. Antimicrob. Chemother. 68:1267-1270. http://dx.doi.org/10.1093/jac/dkt034
- (2013) J. Antimicrob. Chemother , vol.68 , pp. 1267-1270
- Lewis, D.A.¹ Sriruttan, C.² Müller, E.E.³ Golparian, D.⁴ Gumede, L.⁵ Fick, D.⁶ De Wet, J.⁷ Maseko, V.⁸ Coetzee, J.⁹ Unemo, M.¹⁰

4
- 84872054118
- Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada
- Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE. 2013. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 309:163-170. http://dx.doi.org/10.1001/jama.2012.176575
- (2013) JAMA , vol.309 , pp. 163-170
- Allen, V.G.¹ Mitterni, L.² Seah, C.³ Rebbapragada, A.⁴ Martin, I.E.⁵ Lee, C.⁶ Siebert, H.⁷ Towns, L.⁸ Melano, R.G.⁹ Low, D.E.¹⁰

5
- 84891462477
- Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia
- Chen YM, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, Lahra M, Whiley D, Hogg G. 2013. Failure of ceftriaxone 500 mg to eradicate pharyngeal gonorrhoea, Australia. J. Antimicrob. Chemother. 68:1445- 1447. http://dx.doi.org/10.1093/jac/dkt017
- (2013) J. Antimicrob. Chemother. , vol.68 , pp. 1445-1447
- Chen, Y.M.¹ Stevens, K.² Tideman, R.³ Zaia, A.⁴ Tomita, T.⁵ Fairley, C.K.⁶ Lahra, M.⁷ Whiley, D.⁸ Hogg, G.⁹

6
- 84864993313
- Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer recommended for treatment of gonococcal infections. MMWR Morb
- Centers for Disease Control and Prevention
- Centers for Disease Control and Prevention. 2012. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer recommended for treatment of gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 61:590-594.
- (2012) Mortal. Wkly. Rep. , vol.61 , pp. 590-594

7
- 84879495636
- 2012 Europeanguidelineonthe diagnosisandtreatment ofgonorrhoeain adults
- European STI Guidelines Editorial Board
- Bignell C, Unemo M, European STI Guidelines Editorial Board. 2013. 2012 Europeanguidelineonthe diagnosisandtreatment ofgonorrhoeain adults. Int. J. STD AIDS 24:85-92. http://dx.doi.org/10.1177/0956462412472837
- (2013) Int. J. STD AIDS , vol.24 , pp. 85-92
- Bignell, C.¹ Unemo, M.²

8
- 84900495622
- Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options, abstr SO8.1
- Kirkcaldy RD. 2013. Treatment of gonorrhoea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options, abstr SO8.1. STI & AIDS World Congress 2013, Vienna, Austria, 14 to 17 July 2013
- (2013) STI & AIDS World Congress 2013, Vienna, Austria, 14 to 17 July 2013
- Kirkcaldy, R.D.¹

9
- 65749101194
- Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes
- Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63:1142-1151. http://dx.doi.org/10 .1093/jac/dkp098
- (2009) J. Antimicrob. Chemother , vol.63 , pp. 1142-1151
- Unemo, M.¹ Fasth, O.² Fredlund, H.³ Limnios, A.⁴ Tapsall, J.⁵

10
- 0029078189
- Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae
- Hagman KE, Shafer WM. 1995. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J. Bacteriol. 177:4162-4165
- (1995) J. Bacteriol , vol.177 , pp. 4162-4165
- Hagman, K.E.¹ Shafer, W.M.²

11
- 0032842433
- Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations
- Zarantonelli L, Borthagaray G, Lee EH, Shafer WM. 1999. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob. Agents Chemother. 43:2468-2472
- (1999) Antimicrob. Agents Chemother , vol.43 , pp. 2468-2472
- Zarantonelli, L.¹ Borthagaray, G.² Lee, E.H.³ Shafer, W.M.⁴

12
- 84860176932
- In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with various high-level antimicrobial resistance- potential treatment option for gonorrhea? Antimicrob
- Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M. 2012. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with various high-level antimicrobial resistance- potential treatment option for gonorrhea? Antimicrob. Agents Chemother. 56:2739-2742. http://dx.doi.org/10.1128/AAC.00036-12
- (2012) Agents Chemother , vol.56 , pp. 2739-2742
- Golparian, D.¹ Fernandes, P.² Ohnishi, M.³ Jensen, J.S.⁴ Unemo, M.⁵

13
- 84902518287
- A phase 2 study to evaluate the efficacy and safety of single dose solithromycin (CEM-101) for the treatment of patients with uncomplicated urogenital gonorrhoea, abstr O274
- Hook E, III, Oldach D, Jamieson B, Clark K, Fernandes P. 2013. A phase 2 study to evaluate the efficacy and safety of single dose solithromycin (CEM-101) for the treatment of patients with uncomplicated urogenital gonorrhoea, abstr O274. European Congress of Clinical Microbiology and Infectious Disease, Berlin 2013, Berlin, Germany
- (2013) European Congress of Clinical Microbiology and Infectious Disease, Berlin 2013, Berlin, Germany
- Hook III, E.¹ Oldach, D.² Jamieson, B.³ Clark, K.⁴ Fernandes, P.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.